258 related articles for article (PubMed ID: 15193261)
1. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.
O'Neil J; Shank J; Cusson N; Murre C; Kelliher M
Cancer Cell; 2004 Jun; 5(6):587-96. PubMed ID: 15193261
[TBL] [Abstract][Full Text] [Related]
2. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
[TBL] [Abstract][Full Text] [Related]
3. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
4. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
Hsu HL; Wadman I; Tsan JT; Baer R
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
7. The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition.
Park ST; Sun XH
J Biol Chem; 1998 Mar; 273(12):7030-7. PubMed ID: 9507011
[TBL] [Abstract][Full Text] [Related]
8. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.
Huang S; Brandt SJ
Mol Cell Biol; 2000 Mar; 20(6):2248-59. PubMed ID: 10688671
[TBL] [Abstract][Full Text] [Related]
9. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the role of E2A-encoded proteins in insulin gene transcription.
Sharma A; Henderson E; Gamer L; Zhuang Y; Stein R
Mol Endocrinol; 1997 Oct; 11(11):1608-17. PubMed ID: 9328343
[TBL] [Abstract][Full Text] [Related]
11. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
Hofmann TJ; Cole MD
Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
[TBL] [Abstract][Full Text] [Related]
12. E2A/HEB and Id3 proteins control the sensitivity to glucocorticoid-induced apoptosis in thymocytes by regulating the SRG3 expression.
Ko M; Ahn J; Lee C; Chung H; Jeon SH; Chung HY; Seong RH
J Biol Chem; 2004 May; 279(21):21916-23. PubMed ID: 15016815
[TBL] [Abstract][Full Text] [Related]
13. Functional replacement of the mouse E2A gene with a human HEB cDNA.
Zhuang Y; Barndt RJ; Pan L; Kelley R; Dai M
Mol Cell Biol; 1998 Jun; 18(6):3340-9. PubMed ID: 9584174
[TBL] [Abstract][Full Text] [Related]
14. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
Hsu HL; Wadman I; Baer R
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
[TBL] [Abstract][Full Text] [Related]
15. Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB.
Barndt RJ; Dai M; Zhuang Y
Mol Cell Biol; 2000 Sep; 20(18):6677-85. PubMed ID: 10958665
[TBL] [Abstract][Full Text] [Related]
16. Regulation of pT alpha gene expression by a dosage of E2A, HEB, and SCL.
Tremblay M; Herblot S; Lecuyer E; Hoang T
J Biol Chem; 2003 Apr; 278(15):12680-7. PubMed ID: 12566462
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB activation in premalignant mouse tal-1/scl thymocytes and tumors.
O'Neil J; Ventura JJ; Cusson N; Kelliher M
Blood; 2003 Oct; 102(7):2593-6. PubMed ID: 12816868
[TBL] [Abstract][Full Text] [Related]
18. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract][Full Text] [Related]
19. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
20. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
